eQcell Overview
- Year Founded
-
2010
- Status
-
Private
- Employees
-
13
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$848K
- Investors
-
2
eQcell General Information
Description
Developer of regenerative medicine designed to pioneer allogeneic equine cord blood stem cells and canine adipose-derived mesenchymal stromal cells. The company's advanced therapies offer increased efficacy and predictability compared to current autologous stem cell treatment by leveraging data from companion animals with diverse genetic variability, living in varied environments, and receiving similar disease treatments as humans, providing veterinarians with off-the-shelf therapeutics and revolutionizing animal healthcare through innovative, evidence-based solutions.
Contact Information
Website
www.eqcell.comCorporate Office
- 50 Stone Road East
- University of Guelph
- Guelph, Ontario N1G 2W1
- Canada
Corporate Office
- 50 Stone Road East
- University of Guelph
- Guelph, Ontario N1G 2W1
- Canada
eQcell Timeline
eQcell Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Later Stage VC | 15-Jul-2022 | $848K | Completed | Pre-Clinical Trials | ||
| 2. Later Stage VC | 07-Dec-2021 | Completed | Product In Beta Test | |||
| 1. Accelerator/Incubator | 29-Apr-2020 | $30K | $30K | Completed | Product In Beta Test |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
eQcell Comparisons
Industry
Financing
Details
eQcell Competitors (1)
One of eQcell’s competitors is Boehringer Ingelheim, a Corporation company based in Ingelheim Am Rhein, Germany.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Boehringer Ingelheim | Corporation | Ingelheim Am Rhein, Germany |
eQcell Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
eQcell Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
eQcell Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Ag Capital Canada | Growth/Expansion | Minority | ||
| The Accelerator Centre | Accelerator/Incubator | Minority |
eQcell FAQs
-
When was eQcell founded?
eQcell was founded in 2010.
-
Where is eQcell headquartered?
eQcell is headquartered in Guelph, Canada.
-
What is the size of eQcell?
eQcell has 13 total employees.
-
What industry is eQcell in?
eQcell’s primary industry is Other Pharmaceuticals and Biotechnology.
-
Is eQcell a private or public company?
eQcell is a Private company.
-
What is the current valuation of eQcell?
The current valuation of eQcell is .
-
What is eQcell’s current revenue?
The current revenue for eQcell is .
-
How much funding has eQcell raised over time?
eQcell has raised $4.67M.
-
Who are eQcell’s investors?
Ag Capital Canada and The Accelerator Centre have invested in eQcell.
-
Who are eQcell’s competitors?
Boehringer Ingelheim is a competitor of eQcell.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
